Skip to content
healthcare.dev
Get a free key

OXCARBAZEPINE

NDC 60505-4130, OXCARBAZEPINE, tablet, extended release, from Apotex Corp..

Product NDC
60505-4130
Status
Listed
Labeler
Apotex Corp.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213369
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60505-4130 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OXCARBAZEPINE600 mg/1

Pharmacologic classes

Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
60505-4130-560505413005500 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-4130-5)
60505-4130-760505413007100 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-4130-7)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a20e4a95-8ee1-e702-003e-e353ec1ee133

  • NADAC price for package 60505413007

    GET /v1/drugs/nadac/60505413007

Use it

Look up 60505-4130 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60505-4130 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60505-4130. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.